Literature DB >> 18391093

Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.

Xin Xu1, John Fassett, Xinli Hu, Guangshuo Zhu, Zhongbing Lu, Yunfang Li, Jurgen Schnermann, Robert J Bache, Yingjie Chen.   

Abstract

This study examined whether endogenous extracellular adenosine acts to facilitate the adaptive response of the heart to chronic systolic overload. To examine whether endogenous extracellular adenosine can protect the heart against pressure-overload-induced heart failure, transverse aortic constriction was performed on mice deficient in extracellular adenosine production as the result of genetic deletion of CD73. Although there was no difference in left ventricular size or function between CD73-deficient mice (knockout [KO] mice) and wild-type mice under unstressed conditions, aortic constriction for 2 or 4 weeks induced significantly more myocardial hypertrophy, left ventricular dilation, and left ventricular dysfunction in KO mice compared with wild-type mice. Thus, after 2 weeks of transverse aortic constriction, left ventricular fractional shortening decreased to 27.4+/-2.5% and 21.9+/-1.7% in wild-type and KO mice, respectively (P<0.05). Consistent with a role of adenosine in reducing tissue remodeling, KO mice displayed increased myocardial fibrosis and myocyte hypertrophy compared with wild-type mice. Furthermore, adenosine treatment reduced phenylephrine-induced cardiac myocyte hypertrophy and collagen production in cultured neonatal rat cardiac myocytes and cardiac fibroblasts, respectively. Consistent with a role for adenosine in modulating cardiomyocyte hypertrophy, KO mice demonstrated increased activation of mammalian target of rapamycin signaling, accompanied by higher expression of the hypertrophy marker atrial natriuretic peptide. Conversely, the adenosine analogue 2-chloro-adenosine significantly reduced cell size, mammalian target of rapamycin/p70 ribosomal S6 kinase activation, and atrial natriuretic peptide expression in cultured neonatal cardiomyocytes. These data demonstrate that CD73 helps to preserve cardiac function during chronic systolic overload by preventing maladaptive tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391093      PMCID: PMC2398698          DOI: 10.1161/HYPERTENSIONAHA.108.110833

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

1.  CD73/ecto-5'-nucleotidase protects against vascular inflammation and neointima formation.

Authors:  Alma Zernecke; Kiril Bidzhekov; Burcin Ozüyaman; Line Fraemohs; Elisa A Liehn; Juliane M Lüscher-Firzlaff; Bernhard Lüscher; Jürgen Schrader; Christian Weber
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

Review 2.  Adenosinergic cardioprotection: multiple receptors, multiple pathways.

Authors:  Jason N Peart; John P Headrick
Journal:  Pharmacol Ther       Date:  2007-03-12       Impact factor: 12.310

Review 3.  Genetic modulation of adenosine receptor function and adenosine handling in murine hearts: insights and issues.

Authors:  Kevin J Ashton; Jason N Peart; R Ray Morrison; G Paul Matherne; Michael R Blackburn; John P Headrick
Journal:  J Mol Cell Cardiol       Date:  2006-12-29       Impact factor: 5.000

4.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

5.  Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats.

Authors:  Masakatsu Wakeno; Tetsuo Minamino; Osamu Seguchi; Hidetoshi Okazaki; Osamu Tsukamoto; Ken-ichiro Okada; Akio Hirata; Masashi Fujita; Hiroshi Asanuma; Jiyoong Kim; Kazuo Komamura; Seiji Takashima; Naoki Mochizuki; Masafumi Kitakaze
Journal:  Circulation       Date:  2006-10-16       Impact factor: 29.690

6.  Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.

Authors:  Tobias Eckle; Thomas Krahn; Almut Grenz; David Köhler; Michel Mittelbronn; Catherine Ledent; Marlene A Jacobson; Hartmut Osswald; Linda F Thompson; Klaus Unertl; Holger K Eltzschig
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

7.  Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy.

Authors:  Wei Zhang; Thomas Anger; Jialin Su; Jianming Hao; Xiaomei Xu; Ming Zhu; Agnieszka Gach; Lei Cui; Ronglih Liao; Ulrike Mende
Journal:  J Biol Chem       Date:  2005-12-26       Impact factor: 5.157

8.  Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function.

Authors:  Hajime Funakoshi; Tung O Chan; Julie C Good; Joseph R Libonati; Jarkko Piuhola; Xiongwen Chen; Scott M MacDonnell; Ling L Lee; David E Herrmann; Jin Zhang; Jeffrey Martini; Timothy M Palmer; Atsushi Sanbe; Jeffrey Robbins; Steven R Houser; Walter J Koch; Arthur M Feldman
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

9.  Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts.

Authors:  Yinghong Chen; Sara Epperson; Lala Makhsudova; Bruce Ito; Jorge Suarez; Wolfgang Dillmann; Francisco Villarreal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-29       Impact factor: 4.733

10.  Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.

Authors:  Ping Zhang; Xin Xu; Xinli Hu; Elza D van Deel; Guangshuo Zhu; Yingjie Chen
Journal:  Circ Res       Date:  2007-03-15       Impact factor: 17.367

View more
  20 in total

1.  Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.

Authors:  Xinli Hu; Xin Xu; Yimin Huang; John Fassett; Thomas P Flagg; Ying Zhang; Colin G Nichols; Robert J Bache; Yingjie Chen
Journal:  Circ Res       Date:  2008-09-18       Impact factor: 17.367

2.  Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation.

Authors:  Yassine Sassi; Andrea Ahles; Dong-Jiunn Jeffery Truong; Younis Baqi; Sang-Yong Lee; Britta Husse; Jean-Sébastien Hulot; Ariana Foinquinos; Thomas Thum; Christa E Müller; Andreas Dendorfer; Bernhard Laggerbauer; Stefan Engelhardt
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

3.  Variable phenotype in murine transverse aortic constriction.

Authors:  Selma F Mohammed; Jimmy R Storlie; Elise A Oehler; Lorna A Bowen; Josef Korinek; Carolyn S P Lam; Robert D Simari; John C Burnett; Margaret M Redfield
Journal:  Cardiovasc Pathol       Date:  2011-07-18       Impact factor: 2.185

4.  A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.

Authors:  Bernard J C Macatangay; Edwin K Jackson; Kaleab Z Abebe; Diane Comer; Joshua Cyktor; Cynthia Klamar-Blain; Luann Borowski; Delbert G Gillespie; John W Mellors; Charles R Rinaldo; Sharon A Riddler
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

5.  Prevention of RhoA activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes.

Authors:  Asad Zeidan; Xiaohong Tracey Gan; Ashley Thomas; Morris Karmazyn
Journal:  Mol Cell Biochem       Date:  2013-10-06       Impact factor: 3.396

Review 6.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

7.  Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase.

Authors:  Masanori Ohta; Kazuyoshi Toyama; David D Gutterman; William B Campbell; Vincent Lemaître; Ryutaro Teraoka; Hiroto Miura
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

8.  Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2.

Authors:  Xin Xu; Zhongbing Lu; John Fassett; Ping Zhang; Xinli Hu; Xiaoyu Liu; Dongmin Kwak; Jingxin Li; Guangshuo Zhu; Yi Tao; Mingxiao Hou; Huan Wang; Haipeng Guo; Benoit Viollet; Edward O McFalls; Robert J Bache; Yingjie Chen
Journal:  Hypertension       Date:  2014-01-13       Impact factor: 10.190

9.  Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.

Authors:  S-L Puhl; A Kazakov; A Müller; P Fries; D R Wagner; M Böhm; C Maack; Y Devaux
Journal:  Br J Pharmacol       Date:  2015-11-16       Impact factor: 8.739

10.  CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation.

Authors:  Xiaohong Tracey Gan; Seiichi Taniai; Ganjian Zhao; Cathy X Huang; Thomas J Velenosi; Jenny Xue; Bradley L Urquhart; Morris Karmazyn
Journal:  Mol Cell Biochem       Date:  2014-06-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.